Compare StocksABBV vs TJX

AbbVie Inc. (ABBV) vs The TJX Companies, Inc. (TJX): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $251, with a DCF intrinsic value of $178 and a margin of safety of -41%. TJX is overvalued at $157, with an intrinsic value of $116 and a margin of safety of -35%. Of the two, TJX has the wider margin of safety.

ABBV
AbbVie Inc.
$250.94
VS
TJX
The TJX Companies, Inc.
$157.34

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
TJX
  • The TJX Companies, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • The TJX Companies, Inc. scores 94/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • Free cash flow has grown at a 23.2% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
TJX
  • FCF yield of 2.5% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • PEG ratio of 3.36 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • 6 insider sales totaling $27.7M with no purchases in the past 3 months — insiders are reducing their exposure.

Key Valuation Metrics

Learn more →
ABBV
TJX
Valuation
N/A
Free Cash Flow
$4.31B
N/A
FCF Yield
2.48%
70.89
Trailing P/E
30.55
15.41
Forward P/E
27.32
Quality & Moat
27.60%
ROIC
23.30%
N/A
ROE
61.25%
72.79%
Gross Margin
31.35%
0.41
PEG Ratio
3.36
Balance Sheet Safety
N/A
Net Debt / Equity
0.83
N/A
Interest Coverage
N/A
2.06
Net Debt / EBITDA
0.97
2.76%
Dividend Yield
1.22%
ABBV: 5Ties: 1TJX: 2
ABBVTJX

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

TJX

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
TJX
$6.67
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$9.86B
Δ Market Cap
+$65.80B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
40.7% Overvalued
Price is 40.7% above estimated fair value
Current Price: $250.94
Fair Value: $178.31
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
TJX
35.5% Overvalued
Price is 35.5% above estimated fair value
Current Price: $157.34
Fair Value: $116.15
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

TJX

What growth rate is the market pricing in at $157?

+14.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +17.9%

The market implies +14.6% Owner Earnings growth, roughly in line with history — reasonably priced.

Standard FCF implies +17.9%, reflecting ongoing growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
TJX
94/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
TJX
-2.56
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,146
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
TJX
Insiders 0.2%Institutions 93.8%Retail & Other 6.0%
No. of Institutional Holders3,517
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
TJX
0
Buys (3M)
2
Buys (12M)
Total value (12M): $4,199
ALVAREZ JOSE B
Director
$734.00
@ $183.50 · 2026-03-05
ALVAREZ JOSE B
Director
$3,465
@ $133.27 · 2025-12-04
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
TJX
6
Sells (3M)
11
Sells (12M)
Total value (12M): $41.14M
NEMEROV JACKWYN L
Director
$161,345
@ $168.59 · 2026-06-11
BENJAMIN PETER
Officer
$1.80M
@ $165.00 · 2026-06-10
MEYROWITZ CAROL M
Officer and Director
$9.10M
@ $163.65 · 2026-06-09
KLINGER JOHN
Chief Financial Officer
$1.00M
@ $160.77 · 2026-06-05
HERRMAN ERNIE L
Chief Executive Officer
$10.69M
@ $158.29 · 2026-06-05
CANESTRARI KENNETH D
Officer
$4.95M
@ $157.50 · 2026-06-03
HERRMAN ERNIE L
Chief Executive Officer
$4.83M
@ $160.95 · 2026-03-02
HERRMAN ERNIE L
Chief Executive Officer
$8.15M
@ $149.93 · 2025-11-21
LANE AMY BETH
Director
$75,700
@ $151.40 · 2025-11-21
BENJAMIN PETER
Officer
$208,845
@ $139.23 · 2025-09-08
NEMEROV JACKWYN L
Director
$164,496
@ $138.00 · 2025-09-02
LANE AMY BETH
Director
$121,689
@ $128.09 · 2025-06-03
BENJAMIN PETER
Officer
$535,042
@ $129.77 · 2025-05-22
HERRMAN ERNIE L
Chief Executive Officer
$2.10M
@ $116.54 · 2025-03-20
HERRMAN ERNIE L
Chief Executive Officer
$2.88M
@ $123.04 · 2025-03-05
BENNETT ALAN M
Director
$988,254
@ $123.53 · 2025-02-27
HERRMAN ERNIE L
Chief Executive Officer
$950,551
@ $126.18 · 2024-12-05
LANE AMY BETH
Director
$126,925
@ $126.92 · 2024-11-27
HERRMAN ERNIE L
Chief Executive Officer
$2.32M
@ $121.27 · 2024-11-22
NEMEROV JACKWYN L
Director
$139,252
@ $117.71 · 2024-09-12
HERRMAN ERNIE L
Chief Executive Officer
$1.76M
@ $117.54 · 2024-09-10
GREENLEES LOUISE E.
Officer
$555,635
@ $119.23 · 2024-08-22
HERRMAN ERNIE L
Chief Executive Officer
$2.41M
@ $120.47 · 2024-08-22
CHING DAVID T
Director
$1.55M
@ $119.39 · 2024-08-22
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(61/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
TJX
FearGreed
😏Greed(64/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
TJX
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (64)
View ABBV Full AnalysisView TJX Full Analysis

Frequently Asked Questions: ABBV vs TJX

Is AbbVie Inc. or The TJX Companies, Inc. more undervalued in 2026?

Based on our discounted cash flow model, TJX trades at a -35.5% margin of safety (intrinsic value $116 vs. price $157), compared to ABBV's -40.7% margin of safety (intrinsic $178 vs. $251).

Which stock has a wider economic moat, AbbVie Inc. or The TJX Companies, Inc.?

TJX scores 94/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. TJX scores 6.9 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or The TJX Companies, Inc.?

ABBV earns 27.6% ROIC versus TJX's 23.3%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or The TJX Companies, Inc.'s?

TJX's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). TJX has raised its dividend for 3 consecutive years.